about
The NSPCC UK Minding the Baby® (MTB) home-visiting programme, supporting young mothers (aged 14-25) in the first 2 years of their baby's life: study protocol for a randomised controlled trial."Sometimes, it just stops me from doing anything": A qualitative exploration of epilepsy management in people with intellectual disabilities and their carers.Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysisWordless intervention for epilepsy in learning disabilities (WIELD): study protocol for a randomized controlled feasibility trial.Identifying depression in South asian patients with end-stage renal disease: considerations for practiceA study of sertraline in dialysis (ASSertID): a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis.Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis.Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study.Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest.The size, burden and cost of disorders of the brain in the UK.Wordless intervention for people with epilepsy and learning disabilities (WIELD): a randomised controlled feasibility trialThe Herts and minds study: evaluating the effectiveness of mentalization-based treatment (MBT) as an intervention for children in foster care with emotional and/or behavioural problems: a phase II, feasibility, randomised controlled trial.Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome?18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers--an audit and review of published studies.Medication beliefs are associated with phosphate binder non-adherence in hyperphosphatemic haemodialysis patients.Can simvastatin improve erectile function and health-related quality of life in men aged ≥40 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [ISRCTN66772971].Can simvastatin improve erectile function and health-related quality of life in men aged >40 years with erectile dysfunction? Rationale and design of the Erectile Dysfunction and Statins (EDS) Trial [ISRCTN66772971](1).Evidence of improved fluid management in patients receiving haemodialysis following a self-affirmation theory-based intervention: A randomised controlled trial.An association between depressive symptoms and survival in incident dialysis patients.Distinct depression symptom trajectories over the first year of dialysis: associations with illness perceptions.Auditory memory for timbre.A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomas.Shear-induced global thrombosis test of native blood: pivotal role of ADP allows monitoring of P2Y12 antagonist therapy.Influence of N-butylscopolamine on SUV in FDG PET of the bowel.Evidence that self-affirmation improves phosphate control in hemodialysis patients: a pilot cluster randomized controlled trial.Illness perceptions predict survival in haemodialysis patients.Illness representations are associated with fluid nonadherence among hemodialysis patients.You cannot choose your family: sociological ambivalence in the hemodialysis unit.Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin.Disease-specific predictive formulas for energy expenditure in the dialysis population.Assessment of the spatial pattern of colorectal tumour perfusion estimated at perfusion CT using two-dimensional fractal analysis.A pilot study of the epilepsy risk awareness checklist (ERAC) in people with epilepsy and learning disabilities.Scan-time reduction using noise-matched images in 2- and 3-dimensional bismuth germanate PET/CT: clinical study in head and neck cancer.Perfusion CT assessment of the colon and rectum: feasibility of quantification of bowel wall perfusion and vascularization.Quantitative helical dynamic contrast enhanced computed tomography assessment of the spatial variation in whole tumour blood volume with radiotherapy in lung cancerThe factor structure of the revised illness perception questionnaire (IPQ-R) in end-stage renal disease patientsChoosing Not to Take Phosphate Binders: The Role of Dialysis Patients’ Medication BeliefsA confirmatory factor analysis of the beck depression inventory-II in end-stage renal disease patientsIllness representations and concurrent depression symptoms in haemodialysis patientsDepression in End-Stage Renal Disease: Current Advances and Research
P50
Q30819604-DB29E264-1B04-4DDC-A226-D073FC6E7306Q30830980-30F33CF4-4A22-4A89-95B1-4C54DF579A7AQ33560502-DEAB6EDA-B380-4AC5-9249-5AF3F851B7C5Q34898157-314C2D19-E732-4E3A-B0B4-7153141EA12CQ35791742-0B31BCD0-9334-49FE-82FB-165652A691CAQ35821850-C1DA0079-1D9A-4B25-B99C-3EAAD8C40712Q36443197-A35463F1-7367-4E78-97F5-95C79C79308CQ36785948-6D869BBA-1441-4CC9-972B-9490ADD58DACQ37135007-3CBA750B-9307-4804-8A47-354C6434C331Q37187560-FF1D2527-3925-4AE1-9AE1-BA71BFDA111DQ37454268-C5E52271-9DC7-4F0F-9E4B-699568D6D916Q37658445-E5953750-BFED-4C0A-AF52-317D6FD5FBF0Q37695652-FC38D32F-F9EA-4E0C-A3CF-45AABB53E6C7Q37969913-194609A5-E619-4C4C-A88B-97E28960E1A5Q38447738-C410E186-9C2A-4326-A5F2-AD5E142EBFD4Q39604956-14A95DD9-58CE-4C41-9ABF-713BC6A8BE27Q39775989-5C12EF17-9177-4504-A72D-7B1A381853C7Q40654599-5446CE9E-0939-425E-9A88-D9F6A72A6B9AQ43790679-19208881-F37F-49D1-8D68-45FB327213CBQ45182540-6CF13297-8EA1-44D0-8CC0-62793E9B9FA7Q45716681-96B9EFF5-BF74-48AE-ABDD-1F6AA7998C70Q45956300-84E19A64-359F-4CCD-B887-28E0AC46D182Q45992480-E1AD8D25-F130-4966-B640-1E5B1DA94994Q46010971-FEB993A7-30F1-47B9-AE34-AEC1435D510AQ46610764-8B5B3CBF-445F-4F22-A420-E7E283833F7CQ48887304-88C5DA3D-4371-4F3F-B118-0FA40271878FQ48899478-A0657C9F-9847-4A66-8217-6D7545549A8AQ50623528-0D7C0A6C-2CCD-4460-A34C-11C93DD5FBF4Q50703049-36FD5453-D973-46E8-8333-2EEBD9A88B25Q51090454-F789E816-D7FA-4022-A440-F7175ADB435BQ51853080-0053CDCC-3B87-492D-86A0-F96E3E729A46Q51897797-04686D53-B018-4AC8-B76C-C14D2159DB61Q53056427-01CF2193-FF1D-4173-BC5D-2983F11D4712Q53239250-31F34C8E-A3F9-43FF-BC3D-C56C35D00BBAQ56744968-3E95246F-8D86-4E60-BDE9-A0B897881006Q58220962-409F2986-407C-4CA5-A1B4-CAEBB4C8C88BQ58220966-DDB89517-5C53-4538-98D3-E1124039C7FBQ58220968-B63EFD5E-6507-404B-9F04-6C7C26BD4CD6Q61830628-17B17D6B-3B26-4363-A0D5-E3CB89C966B9Q61830636-65AE8A59-F790-4DE1-B1D6-B1F59061F48A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David Wellsted
@ast
David Wellsted
@en
David Wellsted
@es
David Wellsted
@nl
David Wellsted
@sl
type
label
David Wellsted
@ast
David Wellsted
@en
David Wellsted
@es
David Wellsted
@nl
David Wellsted
@sl
prefLabel
David Wellsted
@ast
David Wellsted
@en
David Wellsted
@es
David Wellsted
@nl
David Wellsted
@sl
P106
P21
P31
P496
0000-0002-2895-7838